TFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021

NEXT STORY
Enzyvant Announces Publication of Positive Clinical Data in Pediatric Patients with Congenital Athymia Treated with Investigational RVT-802 (allogeneic processed thymus tissue-agdc)
PREV STORY
Global Nucleic Acid Isolation and Purification Markets 2021-2031: Emergence of Advanced Stabilization Products / Regulated vs. Multimodal / Novel Targets / New Applications
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ovid Therapeutics Provides 2020 Update in Preparation for Multiple Clinical Data Readouts Across Rare Neurological Disease Platform

author_avatar
NASDAQ Market News

MediPharm Labs First to Launch THC-Free, 99% Pure CBD Isolate Consumer Sized Crystal in Canada

author_avatar
NASDAQ Market News

OliX Pharmaceuticals Expands Scientific Advisory Board with Addition of Leading Liver Experts

author_avatar
NASDAQ Market News